Adaptin Bio (APTN) Other Non-Current Liabilities (2025 - 2026)
Adaptin Bio (APTN) reported Other Non-Current Liabilities of $551269.0 for Q1 2026, little changed on a YoY basis from $551269.0 in Q1 2025, and little changed sequentially from $551269.0 in Q4 2025.
Adaptin Bio (APTN) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends
Adaptin Bio (APTN) has 2 years of Other Non-Current Liabilities data on file, last reported at $551269.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $551269.0; the trailing twelve-month figure through Mar 2026 stood at $551269.0 (changed 0.0% YoY), and the FY2025 full-year result was $551269.0, changed N/A from the prior year.
- Other Non-Current Liabilities steadied at $551269.0 in Q1 2026, from $551269.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $551269.0 in Q1 2025 to a low of $551269.0 in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551,269.00 |
| Dec 31, 2025 | 551,269.00 |
| Sep 30, 2025 | 551,269.00 |
| Jun 30, 2025 | 551,269.00 |
| Mar 31, 2025 | 551,269.00 |